Combined with report indicating that PD-L1 was correlated with p53 in NSCLC and oral squamous cell carcinoma,14,15 EBV insertion can be assumed to promote the expression of BART5-3P, consequently inhibiting p53 and PD-L1. Here, TP53 is linked to non-small cell lung carcinoma.